[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]

[[ timeLabel ]] WATCH LIVE:

Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial

Faster, Cleaner, Better.

G1 Therapeutics Inc (GTHX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Cash Flow for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	03-2018	12-2017	09-2017	06-2017	03-2017
Cash Flows From Operating Activities
Net Income	-20,410	-60,121	-43,140	-27,539	-12,345
Depreciation Amortization	32	89	59	32	12
Other Working Capital	675	6,072	4,904	4,132	2,464
Other Operating Activity	1,594	3,441	2,404	1,358	589
Operating Cash Flow	$-18,109	$-50,519	$-35,773	$-22,017	$-9,280

Cash Flows From Investing Activities
PPE Investments	-71	-294	-270	-34	-13
Investing Cash Flow	$-71	$-294	$-270	$-34	$-13

Cash Flows From Financing Activities
Common Stock Issued	109,071	108,718	108,516	108,516	1
Common Stock Repurchased	-316	-1,398	-1,398	-1,095	-286
Financing Cash Flow	$108,755	$107,320	$107,118	$107,421	$-285

Beginning Cash Position	103,812	47,305	47,305	47,305	47,305
End Cash Position	194,387	103,812	118,380	132,675	37,727
Net Cash Flow	$90,575	$56,507	$71,075	$85,370	$-9,578

Free Cash Flow
Operating Cash Flow	-18,109	-50,519	-35,773	-22,017	-9,280
Capital Expenditure	-71	-294	-270	-34	-13
Free Cash Flow	-18,180	-50,813	-36,043	-22,051	-9,293